All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

CJC-1295 with Semaglutide: Stacking Guide

Complete stacking guide for CJC-1295 with semaglutide. Build an effective peptide-GLP-1 stack with proper dosing, timing, cycling, and add-on options.

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

CJC-1295 with Semaglutide: Stacking Guide custom 2026 header image for Peptide Therapy
Custom header image for CJC-1295 with Semaglutide: Stacking Guide, Peptide Therapy, and better treatment decision-making.
In This Article

This article is part of our Peptide Therapy collection. See also: GLP-1 Guides | Provider Comparisons

Search and AI answer brief

Practical answer: CJC-1295 with Semaglutide: Stacking Guide

Complete stacking guide for CJC-1295 with semaglutide. Build an effective peptide-GLP-1 stack with proper dosing, timing, cycling, and add-on options.

Short answer

Complete stacking guide for CJC-1295 with semaglutide. Build an effective peptide-GLP-1 stack with proper dosing, timing, cycling, and add-on options.

Search intent

This page answers a specific Peptide Therapy question rather than a generic overview.

What to verify

semaglutide, peptide evidence quality, cash price and coverage terms, safety and contraindications

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Complete stacking guide for CJC-1295 with semaglutide. Build an effective peptide-GLP-1 stack with proper dosing, timing, cycling, and add-on options.

Stacking CJC-1295 with semaglutide creates a potent combination of sustained growth hormone improvement and GLP-1-driven fat loss. Semaglutide provides the appetite suppression and metabolic regulation that drive weight loss. CJC-1295 provides extended growth hormone stimulation to preserve lean muscle, improve sleep, enhance recovery, and support fat metabolism. This stacking guide covers every aspect of building and managing this combination under physician supervision.

Why Stack CJC-1295 Specifically?

Among the growth hormone peptides available for stacking with GLP-1 medications, CJC-1295 stands out for its duration of action. While sermorelin requires nightly injections and produces brief GH pulses, CJC-1295 (especially the DAC form) provides sustained GH elevation that can last days from a single injection.

This makes CJC-1295 particularly attractive for patients who:

  • Want fewer total injections per week
  • Prefer consistent, around-the-clock GH support rather than overnight-only pulses
  • Are already committed to weekly semaglutide injections and want a simple add-on schedule
  • Have tried shorter-acting peptides and want a more sustained option

The trade-off is that CJC-1295 with DAC is harder to dose-adjust quickly (its effects linger for days), and it carries a slightly higher risk of water retention. These are manageable considerations, not dealbreakers. peptide therapy options

Stack Components in Detail

Semaglutide: The Weight Loss Engine

  • Type: GLP-1 receptor agonist
  • Mechanism: Appetite suppression, slowed gastric emptying, improved insulin sensitivity
  • Dose range: 0.25 to 2.4 mg weekly
  • Half-life: ~7 days
  • Administration: Subcutaneous injection, once weekly
  • Clinical weight loss: 12 to 17% of body weight average in trials

From $299

Popular Therapeutic Peptides by Use Case Clinical Interest Score 0 22 44 66 88 88 82 78 75 70 BPC-157 TB-500 Sermorelin Ipamorelin GHK-Cu Based on published peptide research literature
Popular Therapeutic Peptides by Use Case. Based on published peptide research literature.
View data table
Bar chart showing popular therapeutic peptides by use case: BPC-157 (88), TB-500 (82), Sermorelin (78), Ipamorelin (75), GHK-Cu (70)
CategoryClinical Interest ScoreDetail
BPC-15788Tissue repair and gut healing
TB-50082Injury recovery
Sermorelin78Growth hormone support
Ipamorelin75Anti-aging and recovery
GHK-Cu70Skin and tissue repair
Illustration for CJC-1295 with Semaglutide: Stacking Guide

CJC-1295: The Growth Hormone Foundation

  • Type: GHRH analog (with or without DAC)
  • Mechanism: Stimulates pituitary GH release through GHRH receptors
  • Dose range: 1 to 2 mg weekly (DAC) or 100 to 300 mcg per dose (no DAC)
  • Half-life: 6 to 8 days (DAC) or ~30 minutes (no DAC)
  • Administration: Subcutaneous injection
  • Primary benefits: Muscle preservation, sleep enhancement, fat metabolism, recovery

Contact provider for current pricing

Building Your Stack: Complete Roadmap

Pre-Stack: Medical Evaluation

Every stack begins with a thorough evaluation:

CJC-1295 / Ipamorelin Blend

From the FormBlends catalog

CJC-1295 / Ipamorelin Blend

The gold standard growth hormone secretagogue stack · From $69/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.

Learn about CJC-1295 / Ipamorelin Blend →
  • Complete health history review
  • Current medication and supplement assessment
  • Contraindication screening (active cancer, MTC history, pituitary disorders)
  • Baseline labs: CMP, HbA1c, IGF-1, lipid panel, thyroid function, CBC
  • Body composition measurement (DEXA preferred)
  • Goal setting and protocol discussion

Medical evaluation at FormBlends

Week 1: Start Semaglutide

Begin semaglutide at 0.25 mg weekly. This introductory dose lets your GI system adapt. Most patients experience mild nausea that improves within 1 to 2 weeks. Focus on hydration and eating small, protein-focused meals. For a complete cost breakdown, see our semaglutide pricing comparison.

Week 5: Increase Semaglutide

Move to 0.5 mg weekly if the introductory dose was well tolerated. Appetite suppression and early weight loss typically begin at this dose. Continue monitoring GI symptoms.

Weeks 6 to 8: Introduce CJC-1295

Once semaglutide is stable at 0.5 mg or higher for 2+ weeks, add CJC-1295:

  • DAC form: Start at 1 mg, once weekly. Assess tolerance over 2 to 3 weeks before considering dose increase.
  • No-DAC form: Start at 100 mcg, once nightly at bedtime on empty stomach. Increase to 200 to 300 mcg over 2 weeks as tolerated.

Weeks 10 to 12: First Lab Check

Draw IGF-1, fasting glucose, and CMP. These results guide dose improvement for CJC-1295 and confirm glucose stability.

Month 3 Onward: Improve and Monitor

Continue titrating semaglutide upward as needed (1.0 mg, 1.7 mg, up to 2.4 mg). Maintain CJC-1295 at the established dose. Recheck labs every 3 months. Adjust based on IGF-1, glucose, body composition data, and clinical response.

Dosing Quick Reference

Medication Form Start Maintenance Frequency Timing
Semaglutide Injectable 0.25 mg 0.5 to 2.4 mg Weekly Any consistent day/time
CJC-1295 With DAC 1 mg 1 to 2 mg 1 to 2x weekly Any time. often same day as semaglutide
CJC-1295 No DAC 100 mcg 100 to 300 mcg 1 to 3x daily Bedtime primary. fasted

Timing and Injection Management

CJC-1295 with DAC Timing

Because of its extended half-life, CJC-1295 with DAC is flexible on timing. Many patients find it convenient to inject on the same day as semaglutide, using a different injection site and different syringe. Morning injections are common since there's no fasting requirement with the DAC form.

CJC-1295 without DAC Timing

The no-DAC form is time-sensitive:

  • Primary dose: Bedtime, at least 2 hours after last meal (food, especially carbs and fat, suppresses the GH response)
  • Optional second dose: Upon waking, before breakfast (fasted)
  • Optional third dose: 30 to 60 minutes before exercise (fasted or near-fasted)

Injection Site Rotation

Rotate among abdomen (2+ inches from navel), front of thigh, and back of upper arm. Never inject two medications at the same site on the same day. Keep a simple injection log to track rotation.

Expanding the Stack: Add-On Peptides

Once the base CJC-1295 and semaglutide stack is stable (typically 8 to 12 weeks in), some protocols add complementary peptides:

Peptide Role How It Integrates Typical Dose
Ipamorelin Growth hormone-releasing peptide (GHRP) Co-injected with CJC-1295 no DAC at bedtime for amplified GH pulse 100 to 300 mcg
BPC-157 Body-protective compound May support GI comfort during semaglutide. tissue repair 250 to 500 mcg daily
Tesamorelin GHRH analog (FDA-approved for lipodystrophy) Alternative to CJC-1295 with more targeted visceral fat data Per prescribing information

The CJC-1295 plus ipamorelin combination is one of the most widely used peptide stacks in clinical practice. Ipamorelin triggers acute GH release while CJC-1295 provides the GHRH signal that amplifies and sustains it. When paired with semaglutide, this creates a three-component stack with excellent body composition potential. ipamorelin therapy

We recommend keeping the stack as simple as possible. Each additional component adds cost, complexity, and monitoring requirements. Master the base stack before expanding.

Cycling Your CJC-1295

CJC-1295 with DAC

Cycling is generally recommended due to sustained receptor stimulation. Common patterns:

  • 8 weeks on, 4 weeks off
  • 12 weeks on, 4 weeks off

During the off period, some patients substitute sermorelin (shorter-acting) to maintain some GH support without continuous GHRH receptor stimulation.

CJC-1295 without DAC

Less strict cycling is needed due to the shorter half-life. Options:

  • 5 days on, 2 days off each week
  • Continuous dosing with quarterly IGF-1 monitoring to guide breaks if needed

Semaglutide

Not cycled. Used continuously through the weight loss phase, then tapered for maintenance.

Nutrition Strategy

Your nutrition determines whether the stack reaches its potential:

Protein

This is the most important macronutrient for this stack. Target 0.7 to 1.0 grams per pound of target body weight. Without sufficient protein, even improved GH levels can't fully protect lean muscle. High-protein foods include chicken breast, fish, eggs, Greek yogurt, lean beef, and whey protein.

Meal Timing

  • If using CJC-1295 no DAC at bedtime: stop eating 2+ hours before injection
  • Eat smaller, more frequent meals to manage semaglutide GI effects
  • Front-load calories earlier in the day if evening fasting is challenging

Hydration

Especially important with this stack. CJC-1295 DAC can cause mild water retention, and semaglutide's GI effects are worsened by dehydration. Aim for at least half your body weight in ounces of water daily.

Exercise Framework

  • Resistance training (3 to 4x/week): The single most impactful exercise for this stack. Compound movements (squats, deadlifts, presses, rows) stimulate the most muscle groups and trigger additional natural GH release.
  • Moderate cardio (2 to 3x/week): Walking, cycling, swimming. 20 to 40 minutes. Avoid excessive endurance training during significant caloric restriction.
  • Recovery focus: CJC-1295 supports recovery, but allow 48 hours between resistance sessions targeting the same muscle groups. Sleep is your top recovery tool.

Expected Results Timeline

Phase Timeline What to Expect
Semaglutide adaptation Weeks 1 to 4 GI adjustment, mild appetite changes, minimal weight loss
Active weight loss begins Weeks 5 to 8 Appetite suppression, 1 to 2 lbs/week loss, CJC-1295 introduction
Full stack active Months 2 to 3 Sleep improvement, energy increase, steady weight loss, early body composition changes
Peak improvement Months 3 to 6 Significant cumulative fat loss, visible muscle preservation, improved lab markers
Approaching goals Months 6 to 12 Nearing target weight, body composition refinement, maintenance planning

Common Mistakes

  • Starting CJC-1295 DAC at too high a dose. The long half-life means side effects persist. Start low.
  • Eating before CJC-1295 no-DAC injection. Blunts the GH response significantly.
  • Neglecting protein intake. The number one nutrition mistake. Track it.
  • Skipping labs. IGF-1 monitoring is important, especially with CJC-1295 DAC.
  • Expecting scale weight to tell the whole story. Body composition is what matters. Use DEXA scans or measurements, not just scale weight.
  • Not rotating injection sites. Leads to tissue irritation and inconsistent absorption.
  • Adjusting doses without physician guidance. Both medications require clinical oversight for changes.

Frequently Asked Questions

CJC-1295 is a prescription peptide available through compounding pharmacies. When prescribed by a licensed physician based on a medical evaluation, its use is legal. It isn't an FDA-approved medication but is available under compounding regulations.

How does the cost compare to a sermorelin-semaglutide stack?

Costs vary by pharmacy, dose, and form. CJC-1295 with DAC may cost more per vial but requires fewer doses. CJC-1295 without DAC is often priced comparably to sermorelin. Our team provides specific pricing during consultation. Contact provider for current pricing

Can women use this stack?

Yes. This stack is appropriate for both men and women. Dosing is individualized. Women who are pregnant, breastfeeding, or planning pregnancy shouldn't use either medication.

What if I am already on sermorelin and want to switch to CJC-1295?

Your physician can manage the transition. Typically, you would stop sermorelin and begin CJC-1295 in the same or following week. No washout period is needed since both target the same receptor pathway. Semaglutide continues unchanged throughout the switch.

Can I combine CJC-1295 with DAC and CJC-1295 without DAC?

This is uncommon and generally unnecessary. Choose one form or the other. Using both adds complexity without clear benefit.

How long can I safely stack these medications?

Semaglutide can be used for 12+ months continuously. CJC-1295 is typically used in cycles (8 to 12 weeks on, 4 weeks off for DAC. more flexible for no-DAC). Your physician determines duration based on your progress and goals.

Stack with Confidence

The CJC-1295 and semaglutide stack offers sustained growth hormone support paired with one of the most effective weight loss medications available. Whether you choose the convenience of CJC-1295 with DAC or the pulsatile precision of the no-DAC form, you're building a stack designed to help you lose fat, keep muscle, sleep better, and recover faster. At FormBlends, our physicians design, prescribe, and manage this stack from your first consultation through your last lab check. start your consultation with FormBlends

CJC-1295 / Ipamorelin Blend

Ready when you are

CJC-1295 / Ipamorelin Blend

The gold standard growth hormone secretagogue stack · From $69/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.

Learn about CJC-1295 / Ipamorelin Blend →
Browse the full catalog →

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For CJC-1295 with Semaglutide: Stacking Guide, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

ReviewGrowth-hormone peptide evidence1998

Ipamorelin, the first selective growth hormone secretagogue

Background source for ipamorelin selectivity and GH-secretagogue mechanism.

PubMed

ReviewGrowth-hormone peptide evidence2001

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation

Preclinical context that should not be overstated as consumer clinical evidence.

PubMed

ReviewGrowth-hormone peptide evidence2002

Influence of chronic treatment with the growth hormone secretagogue Ipamorelin

Supports mechanism-level discussion while keeping evidence limits visible.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

CJC-1295 with Semaglutide: Stacking Guide research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Complete stacking guide for CJC-1295 with semaglutide. Build an effective peptide-GLP-1 stack with proper dosing, timing, cycling, and add-on options. The practical reason to read "CJC-1295 with Semaglutide: Stacking Guide" is to separate useful context from easy claims about semaglutide, dosing. It sits in a peptide therapy guide where research status, sourcing, compounding quality, dosing, and clinician oversight all need extra scrutiny and should help with patient education and clinical context. Because this article has 13 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Use the page to sharpen your next question, especially if your health history or medications change the risk profile.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for CJC

For this peptide therapy page, the 2026 refresh focuses on semaglutide, BPC-157, cash-pay pricing, safety signals, cjc, 1295 so the article stays close to the question behind "CJC".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate CJC from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

CJC custom 2026 image for peptide therapy on FormBlends

Custom 2026 image for CJC, peptide therapy, and better treatment decision-making.

Image description: Unique image for this page covering CJC, peptide therapy, safety, cost, provider selection, and patient decision-making.

Download the Peptide Quick Reference Card

A printable 2-page reference covering popular peptides, dosing ranges, stacking protocols, and storage.

Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.